News
BSX
43.48
-1.70%
-0.75
Weekly Report: what happened at BSX last week (0622-0626)?
Weekly Report · 16h ago
3 Value Stocks to Research Further
Barchart · 20h ago
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
Seeking Alpha · 1d ago
Record-setting healthcare M&A activity to extend through H2: PwC
Seeking Alpha · 4d ago
Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity
Seeking Alpha · 4d ago
Boston Scientific Advances Liver Cancer Strategy With New TheraSphere Dosimetry Study
TipRanks · 4d ago
Portfolio check: The biggest SA Quant downgrades over the past week
Seeking Alpha · 4d ago
Boston Scientific Price Target Cut to $65.00/Share From $75.00 by Stifel
Dow Jones · 4d ago
Boston Scientific Is Maintained at Buy by Stifel
Dow Jones · 4d ago
Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $65
Benzinga · 4d ago
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Cronos Group (CRON) and Boston Scientific (BSX)
TipRanks · 4d ago
Boston Scientific price target lowered to $65 from $75 at Stifel
TipRanks · 4d ago
Boston Scientific Is Maintained at Buy by Jefferies
Dow Jones · 5d ago
Boston Scientific Price Target Cut to $67.00/Share From $100.00 by Jefferies
Dow Jones · 5d ago
Jefferies Maintains Buy on Boston Scientific, Lowers Price Target to $67
Benzinga · 5d ago
10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 5d ago
Boston Scientific price target lowered to $67 from $100 at Jefferies
TipRanks · 5d ago
Boston Scientific (BSX) Faces Flat Watchman Revenue As Doctors Combine Heart Procedures
Simply Wall St · 5d ago
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Benzinga · 6d ago
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
NASDAQ · 6d ago
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology and vascular therapies (ICVT), watchman, cardiac rhythm management, and electrophysiology.